AMIA: Enhancing patient safety and quality of care by improving the usability of EHR systems, but ... no sympathy for victims of bad health IT?

A panel of experts from the American Medical Informatics Association have written a paper "<b>Enhancing patient safety and quality of care by improving the usability of electronic health record systems: recommendations from AMIA</b>."<br /><br />The paper is publicly available <a href="http://jamia.bmj.com/content/early/2013/01/24/amiajnl-2012-001458.full.pdf+html" target="_blank">at this link</a> in PDF. <br /><br />The authors are  Blackford Middleton (Harvard Medical School),  Meryl Bloomrosen (AMIA),  Mark A Dente (GE Healthare IT),  Bill Hashmat (CureMD Corp.), Ross Koppel (Dept. of Socology, Univ, of Pennsylvania), J Marc Overhage (Siemens Health Services), Thomas H Payne (U. Washington IT Services),  S Trent Rosenbloom (Vanderbilt Informatics), Charlotte Weaver (Gentiva Health Services) and Jiajie Zhang (University of Texas Health Science Center at Houston).<br /><br />The paper states what has been obvious to this author - and many others - for many years:<br /><br /><blockquote class="tr_bq">ABSTRACT:  In response to mounting evidence that use of electronic medical record systems may cause unintended consequences, and even patient harm, the AMIA Board of Directors convened a Task Force on Usability to examine evidence from the literature and make recommendations. This task force was composed of representatives from both academic settings and vendors of electronic health record (EHR) systems. After a careful review of the literature and of vendor experiences with EHR design and implementation, the task force developed 10 recommendations in four areas: (1) human factors health information technology (IT) research, (2) health IT policy, (3) industry recommendations, and (4) recommendations for the clinician end-user of EHR software. These AMIA recommendations are intended to stimulate informed debate, provide a plan to increase understanding of the impact of usability on the effective use of health IT, and lead to safer and higher quality care with the adoption of useful and usable EHR systems.</blockquote><br />The paper is a respectable start at acknowledgement of the issues ... albeit years late.<br /><br />That said:<br /><br />I noted some typical language in the article characteristic of the reluctance of the health IT industry and its friends to directly confront these issues.  I wrote a letter to the authors that, as I indicate below, not unexpectedly went unanswered except for one individual -- not even a physician -- who's gone out on a limb professionally in the interest of patient's rights, and as a health IT "iconoclast" (i.e., patient advocate) suffered for doing so (<a href="http://www.modernhealthcare.com/article/20130126/MAGAZINE/301269955" target="_blank">link</a>).  The lack of a response to the letter is itself representative, in my opinion, of a pathology that renders more rights to the healthcare computer and its makers than patients.   More on this below.<br /><br /><span style="font-family: inherit;"><span style="font-size: small;">First, I note I am rarely if ever cited by the academics.  They are not prohibited from doing so<span style="font-size: small;">.  <span style="font-size: small;">I've probably been writing on th<span style="font-size: small;">ese issue<span style="font-size: small;">s -- poorly done health IT<span style="font-size: small;">, improper leadership,<span style="font-size: small;"> the turmoil created, etc., </span></span>publicly for longer than anyone else in the domain<span style="font-size: small;">.</span></span></span></span></span></span></span><br /><br /><span style="font-family: inherit;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">I also note that the paper is somewhat in the form o<span style="font-size: small;">f an </span></span></span></span></span></span></span></span>analytical debate.  Analytical debates are relatively ineffective in this domain.  They are like popcorn thrust against a battleship.  The paper, also, appearing as it does in a relatively obscure specialty journal (Journal of the American Medical Informatics Association), will probably get more exposure from this blog post than the entire readership of that journal.  The authors need to be relating these issues in forums that are widely read by citizens and government, not in dusty academic journals - that is, assuming they want the messages to widely diffuse.<br /><br />In my review of the article, I note the following:<br /><br /><blockquote class="tr_bq"><div><span style="font-family: inherit;"><span style="font-size: small;">... In an Agency for<span style="font-size: small;"> </span>Healthcare Research and Quality (AHRQ) workshop on usability<span style="font-size: small;"> </span>in health IT in July 2010, all eight participating vendors<span style="font-size: small;"> </span>agreed that usability was important and many suggested it was a<span style="font-size: small;"> </span>competitive differentiator, although some considered that usability<span style="font-size: small;"> </span>was in the eye of the beholder and that the discipline of<span style="font-size: small;"> </span>usability evaluation was an imperfect science, <b>with results that<span style="font-size: small;"> </span>were not useful.</b></span></span></div></blockquote><div></div><div><br /><span style="font-family: inherit;"><span style="font-size: small;">A paper like this should hav<span style="font-size: small;">e clearly repudiated antiqu<span style="font-size: small;">ated viewpoints like that, n<span style="font-size: small;">ot merely made note of them.   Not taking a stand is a sign of weakness...o<span style="font-size: small;">r symp<span style="font-size: small;">athy.</span></span></span></span></span></span></span></div><div><br /><span style="font-family: inherit;"><span style="font-size: small;"><span style="font-size: small;">As a matter of fact, </span>if leaders such as this <span style="font-size: small;">had </span>paid attention to the 'iconoclasts' and their 'anecdotes', my own mother might not have gone through horrible suffering and death, with me as sad witness as I related to them in my letter below.</span></span><br /><br /><blockquote class="tr_bq"><span style="font-family: inherit;"><span style="font-size: small;">... End-users of EHR systems are ultimately accountable for their<span style="font-size: small;"> </span>safe and effective use, like <b>any tool in clinical care</b>. </span></span></blockquote><br /><span style="font-family: inherit;"><span style="font-size: small;">I see a linguistic <a href="http://en.wikipedia.org/wiki/Sleight_of_hand" target="_blank">sleight of hand</a> via use the word "tool" to describe HIT and trying to blend or homogenize this apparatus with other<span style="font-size: small;"> "tools"</span> in clinical care.<span style="font-size: small;">  </span>The HIT "tool" is <i>unlike any other</i> since no transaction of care can occur without it going through this device, and as such, all care is totally dependent on it.  Further, unlike pharma and medical devices, this "tool" is unvetted and unregulat<span style="font-size: small;">ed<span style="font-size: small;"> but its use f<span style="font-size: small;">orced upon many users.</span></span></span></span></span><br /><br /><blockquote class="tr_bq">... [AMIA] subcommittees reviewed the literature on usability in health IT, current related activities underway at various US Federal agencies, lessons learned regarding usability and human factors in other industries, and current federally funded research activities.</blockquote></div><div><span style="font-family: inherit;"><span style="font-size: small;"></span></span><span style="font-family: inherit;"><span style="font-size: small;"></span></span><br /><div></div><span style="font-family: inherit;"><span style="font-size: small;"></span></span><br /><div><span style="font-family: inherit;"><span style="font-size: small;">Did they speak with the source of the most candid information?  The plaintiff's and defendant's <span style="font-size: small;">B</span>ars<span style="font-size: small;">?</span></span></span><br /><br /><span style="font-family: inherit;"><span style="font-size: small;">Need I <span style="font-size: small;">even a</span>sk that question?</span></span></div><div></div><div><br /><blockquote class="tr_bq"><div><span style="font-family: inherit;">... Recent reports describe the safe and effective use of EHR as a property resulting from the careful integration of multiple factors in a broad sociotechnical framework</span></div></blockquote><br /><span style="font-family: inherit;">This is not merely 'recent<span style="font-size: small;">' news.  </span>T<span style="font-size: small;">he field of <span style="font-size: small;"><b>S</b><span style="font-size: small;"><b>oc</b><span style="font-size: small;"><b>ial Informatics</b> (<a href="http://www.dlib.org/dlib/january99/kling/01kling.html" target="_blank">link</a>), that has studied IT in its social contexts for decades now, has offere<span style="font-size: small;">d</span> observations on the importan<span style="font-size: small;">ce of considering</span></span></span></span></span></span><span style="font-family: inherit;"><span style="font-size: small;"> multiple factors in a broad sociotechnical framework.   The authors all know this - or should know <span style="font-size: small;">this,</span> or should have made it their business to <span style="font-size: small;">know <span style="font-size: small;">this</span>. </span> The statement sounds somewhat prote<span style="font-size: small;">ctive of the HIT and hospital ind<span style="font-size: small;">ustr<span style="font-size: small;">ies</span> for their<span style="font-size: small;"> longstand<span style="font-size: small;">ing </span>negligence towards those issues.</span></span></span></span></span><br /><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><b><span style="font-size: small;">... </span>User error</b> may result in untoward outcomes and unintended negative consequences. These may also occur as a result of poor usability, and may also be an emergent property only demonstrated after system implementation or widespread use.</div></blockquote></div><div><br />I note the use of the term "<b>user error</b>" and lack of the term <span style="font-size: small;">"<b>use error</b>" </span>with significant disdain.  As I wrote <a href="http://hcrenewal.blogspot.com/2011/11/two-opposing-views-of-ehr-1.html" target="_blank">here</a><span style="font-size: small;"> regar<span style="font-size: small;">ding the views of a<span style="font-size: small;"> HIT industry exexcutive holding the myst<span style="font-size: small;">ical <span style="font-size: small;">"</span>American Medical Informatics Certification for Health Information Technology"<span style="font-size: small;">, </span></span></span></span></span> NIST <span style="font-size: small;">itself now defines</span> "use error" (as opposed to "user error<span style="font-size: small;">") as follows:</span><br /><br /><blockquote class="tr_bq"><span style="font-weight: bold;">“Use error”</span> is a term used very specifically by NIST to refer to user interface designs that will engender users to make errors of commission or omission. It is true that users do make errors, but many errors are due not to user error per se but due to designs that are flawed, e.g., poorly written messaging, misuse of color-coding conventions, omission of information, etc. From <span style="font-weight: bold;">"</span><span style="font-weight: bold;">NISTIR 7804: Technical Evaluation, Testing and Validation of the Usability of Electronic Health Records</span>.<span style="font-weight: bold;">"</span> It is available at <a href="http://www.nist.gov/healthcare/usability/upload/Draft_EUP_09_28_11.pdf" rel="nofollow">http://www.nist.gov/healthcare/usability/upload/Draft_EUP_09_28_11.pdf</a> (PDF).</blockquote><div dir="ltr"></div><div dir="ltr"><br />In the article, in<span style="font-size: small;">definites were exchange<span style="font-size: small;">d w<span style="font-size: small;">ith <span style="font-size: small;">what should have been stronger, de<span style="font-size: small;">clarat<span style="font-size: small;">ive</span></span></span></span></span></span> statements, and vice versa:<br /><br /><blockquote class="tr_bq">User error ... <b>may</b> also represent a potential health IT-related error yet to happen.</blockquote></div><div dir="ltr"></div><div dir="ltr"><br />I most decidedly wish they'd stop this "may" verbiage in policy papers like this.</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><b>... Anecdotal </b>reports suggest that these application differences [where clinicians use more than one commercial EHR system] result in an <b>increased training burden </b>for EHR users.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br />"Anecdotal"?  How about <span style="font-size: small;">"obvious to a third grader?" </span><br /><br />"Anecdotal" in academic p<span style="font-size: small;">apers <span style="font-size: small;">often is a ter<span style="font-size: small;">m of derision for in<span style="font-size: small;">conven<span style="font-size: small;">i<span style="font-size: small;">ent tru<span style="font-size: small;">ths such<span style="font-size: small;"> as reports of health IT problems</span>.  Its use often reflects a need for authors using the term (<span style="font-size: small;">per a senior clinici<span style="font-size: small;">a<span style="font-size: small;">n from Victoria, Australia on the 'anecdotes' issue, <a href="http://hcrenewal.blogspot.com/2011/08/from-senior-clinician-down-under.html" target="_blank">link</a>)</span></span></span></span></span></span></span></span></span></span> "to attend revision courses in research methodology and risk management."</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><b><span style="font-size: small;">... </span>Some suggest</b> that the expected gains sought with the adoption of EHR are not yet realized.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br />"Some"?  <span style="font-size: small;">How about "credible experts?<span style="font-size: small;">"</span></span>  "Suggest?"  They merely hint at i<span style="font-size: small;">t?  How a<span style="font-size: small;">bout "opine?"</span></span><br /><span style="font-size: small;"><span style="font-size: small;"> </span></span> </div><div dir="ltr"></div><blockquote class="tr_bq"><div dir="ltr"><span style="font-size: small;">... </span>The design of software applications requires both technical expertise and the ability to <b>completely understand the user’s goal, the user’s workflow, and the socio-technical context of the intent</b></div></blockquote><div dir="ltr"></div><div dir="ltr"><br />In the meantime, AMIA has been promoting national rollout of a technology where<span style="font-size: small;">,</span> most often, the latter does not apply.</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><span style="font-size: small;">To ... <b>transform our healthcare delivery system</b> ... <span style="font-size: small;"></span> clinicians need to use usable, efficient health IT that enhances patient safety and the quality of care.</span></div></blockquote><div dir="ltr"></div><div dir="ltr"><br />This is the ty<span style="font-size: small;">pical h</span>yperenthusiast mantra<span style="font-size: small;">.  W</span>here's the proof?  And, transform into what, exactly?  Vague <span style="font-size: small;">rhet<span style="font-size: small;">oric</span></span> like this in allegedly scientific papers is most unwelcome.</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><b>Some </b>experts <b>suggest</b> that improving the usability of EHR may be critical to the continued successful diffusion of the technology.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br />More weak talk.  Wh<span style="font-size: small;">y</span> not come right out and say <b>"Credible experts opine that ...."?</b></div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr">... While some EHR vendors have adopted user-centered design when developing health information<span style="font-size: small;"> </span>technologies, the practice is not universal and may be difficult to apply to legacy systems.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br /><span style="font-size: small;"><span style="font-family: inherit;">From the patient <span style="font-size: small;">advocacy</span> perspective, <span style="font-size: small;">t</span></span></span>hat's their problem...it's a risk of being in this business.  Patients <span style="font-size: small;">should not be expected to be used as experimental sub<span style="font-size: small;">jects while IT sellers </span>figure out what other industry sectors have long mastered.   Further, they should be held accountable for failures that result in harm.  Another risk of doing business in this sector<span style="font-size: small;"> that <span style="font-size: small;">clinicians</span> have long lea<span style="font-size: small;">rned to live with...</span></span></span></div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr">... Some believe it is <b>difficult or impossible to reliably compare</b> one product with another on the basis of usability given the challenges in assessment of products as implemented.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br />Nothing is "impossible" and again, if it's "difficult", that's the<span style="font-size: small;"> industry's</span> problem.  <span style="font-size: small;"><span style="font-size: small;">There</span> is r</span>isk of being in the business of medicine<span style="font-size: small;"> or medical <span style="font-size: small;">facilitati<span style="font-size: small;">on</span></span>; nobody promised a <span style="font-size: small;">rose garden,<span style="font-size: small;"> and a rose garden should not be exp<span style="font-size: small;">ected<span style="font-size: small;"><span style="font-family: inherit;">.</span></span></span></span></span></span> </div><br /><blockquote class="tr_bq"><div dir="ltr">... Many effects of health IT can be considered to be ‘emergent’ or only discovered after monitoring a system in use</div></blockquote><div dir="ltr"><br /><span style="font-size: small;">One might ask, </span> where's the industry and AMIA been <span style="font-size: small;">regading</span> postmarket surveillance (common in other he<span style="font-size: small;">alth sectors) </span>for the past several decades?</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><span style="font-size: small;">... </span>AMIA believes it is <b>now critical</b> to coordinate and accelerate the numerous efforts underway focusing on the issue of EHR usability.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br /><span style="font-size: small;">Only "n</span>ow?"</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr"><span style="font-size: small;">... </span>Establish an adverse event reporting system for health IT and voluntary health IT event reporting</div></blockquote><div dir="ltr"></div><div dir="ltr"><br />No, no<span style="font-size: small;">, </span>no ...voluntary reporting doesn't work.  Even mandatory reporting is flawed<span style="font-size: small;">, but it's better than voluntary</span>.<br /><br />I <span style="font-size: small;">am <span style="font-size: small;">invariably </span>disappointed by<span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"> <span style="font-size: small;">recommendations like this.  </span></span></span></span></span>I've <span style="font-size: small;">observed repeatedly, <span style="font-size: small;">for example, that </span></span>"volunat<span style="font-size: small;">ary reporting" of EHR problems al<span style="font-size: small;">ready exists - in the form of the FDA MAUDE dat<span style="font-size: small;">abase - and most HIT sellers<span style="font-size: small;">' repo<span style="font-size: small;">rts are absent.  </span></span></span></span></span><span style="font-size: 100%;">See my posts on MAUDE <span style="font-size: 100%;"><a href="http://www.ischool.drexel.edu/faculty/ssilverstein/cases/?loc=cases&sloc=MAUDE">here</a><span style="font-size: small;">,</span> <a href="http://www.ischool.drexel.edu/faculty/ssilverstein/cases/?loc=cases&sloc=maude_death">here</a><span style="font-size: small;"> and <a href="http://hcrenewal.blogspot.com/2011/01/maude-and-hit-risk-mother-mary-what-in.html" target="_blank">here</a>.  </span></span></span><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">(Also, the only one that seems to report may have <a href="http://hcrenewal.blogspot.com/2010/04/healthcare-it-corporate-ethics-101.html" target="_blank">u<span style="font-size: small;">l</span>terior motives</a><span style="font-size: small;">, i.e., restraint of trade</span>.</span></span></span></span></span></span>)</div><div dir="ltr"></div><br /><blockquote class="tr_bq"><div dir="ltr">... A voluntary reporting process could leverage the AHRQ patient safety organizations (PSO) ... This work should be<span style="font-size: small;"> </span>sponsored by the AHRQ.</div></blockquote><div dir="ltr"></div><div dir="ltr"><br />These folks clearly don't want any teeth in this.  AHRQ is a research-ori<span style="font-size: small;">ented government</span> branch, not <span style="font-size: small;">a regulator, no<span style="font-size: small;">r does it have regulatory expertise.</span></span></div><div dir="ltr"><span style="font-size: small;"></span><br /><div><span style="font-size: small;"><span style="font-size: small;">AMIA recommend<span style="font-size: small;">s:</span></span> </span></div><blockquote class="tr_bq"><div dir="ltr"><h4><span style="font-size: small;">Research and promote best practices for safe implementation of EHR</span></h4></div></blockquote><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">In 2013 t</span>his is valuable information in the same sense that advice to use sterile technique during neurosurgery<span style="font-size: small;"> is valuable.</span></span></span><br /><div dir="ltr"></div><br /><div dir="ltr"><span style="font-family: inherit;"><span style="font-family: inherit;"><span style="font-family: inherit;"><span style="font-size: small;"><span style="font-family: inherit;"><span style="font-size: small;"><span style="font-size: small;">"Promoting best practi<span style="font-size: small;">ces" <span style="font-size: small;">has</span> been</span></span> done for decades<span style="font-size: small;">.  </span></span></span></span></span></span></span>Not mentioned is <i><b>avoiding worst practices</b></i>.   I've long written these are not the same thin<span style="font-size: small;">g, as toleration of the <span style="font-size: small;">inappropriate leadership by health IT amat<span style="font-size: small;">eurs (a term I use in the same sense that I am a Radio Amateur, not a telecommunications professional), </span>politic<span style="font-size: small;">s, empire-bu<span style="font-size: small;">ilding and other dysfunction that goes on <span style="font-size: small;">in health IT endeavors negat<span style="font-size: small;">es <span style="font-size: small;">laundry lists of "best practi<span style="font-size: small;">ces.<span style="font-size: small;">"</span></span></span></span></span></span></span></span></span> </div><br /><span style="font-family: inherit;"><span style="font-size: small;"><span style="font-size: small;">W</span>hat is required is to research and <b>abolish worst practices</b>, including the culture and dynamics of the 'health IT-industrial complex.'  I made this point in my very first website in 1998.  <span style="font-size: small;">It appears the authors </span>don't get it and/or won't admit to the dysfunction that goes on in health <span style="font-size: small;">I<span style="font-size: small;">T projects</span></span>.</span></span><br /><span style="font-family: inherit;"><span style="font-size: small;"> </span></span> </div><div dir="ltr"></div><blockquote class="tr_bq"><div id="divRpF57737" style="direction: ltr;"><span style="font-size: small;">... </span>The adoption of useful and usable EHR <b>will </b>lead to safer and higher quality care, and a better return on investment for institutions that adopt them.</div></blockquote><div style="direction: ltr;"></div><div style="direction: ltr;"><br /><b>"Will?"</b>  <span style="font-size: small;">With respect to my o<span style="font-size: small;"><span style="font-size: small;">bservation</span> above about the <span style="font-size: small;">paper's <span style="font-size: small;"><span style="font-size: small;">prominent </span>misuse </span></span></span></span><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-family: inherit;"><span style="font-size: small;">of in<span style="font-size: small;">definites </span></span></span></span></span>vs. stronger declarati<span style="font-size: small;">ve t<span style="font-size: small;">erms</span></span>, t</span>he word <b>"may"</b> would have been the appropriate term here<span style="font-size: small;">.  <span style="font-size: small;">As I wrote about simi<span style="font-size: small;">lar statements from ONC in the NEJM in my 2010 post "</span></span></span><a href="http://hcrenewal.blogspot.com/2010/07/new-england-journal-on-meaningful-use.html" target="_blank">Science or Politics? The New England Journal and The 'Meaningful Use' Regulation for Electronic Health Records</a>"<span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">,</span></span></span> I'm quite disappointed seeing speculation and PR prese<span style="font-size: small;">nted as fact </span>from alleged scientists and scientific organizations.<br /><br />Finally, I wrote the following email letter to the authors<span style="font-size: small;">, to<span style="font-size: small;"> <span style="font-size: small;">which (except for Ross Koppel) I received no reply<span style="font-size: small;">.  While Dr. Koppel (a PhD<span style="font-size: small;">)</span> graciously expressed s<span style="font-size: small;">ympathy for my me and mother, the others (many MD<span style="font-size: small;">'s) </span>were s<span style="font-size: small;">ilent.</span></span></span></span></span></span></div><div style="direction: ltr;"><br /><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">Perhaps the silence is the best indicator of <span style="font-size: small;">their conce<span style="font-size: small;">rn for the rights o<span style="font-size: small;">f computers and HIT merchants relative to the rights of people:</span></span></span></span></span></span></span></span></span><br /><br /></div><blockquote><div style="direction: ltr;"><span style="font-size: small;"><span style="font-family: inherit;"><span style="font-size: small;"><span style="font-family: inherit;"><span class="gI">Mon, Jan 28, 2013 at 1:12 PM</span></span></span></span></span> </div></blockquote><blockquote><div style="direction: ltr;"><span style="font-size: small;"><span style="font-family: inherit;">Dear authors,</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">I've reviewed the new paper "Enhancing patient safety and quality of care by improving the usability of electronic health record systems: recommendations from AMIA" and wanted to express thanks for it.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">It's a good start.  Late, but a good start at returning th<span style="font-size: small;">e</span> health IT domain to credibility and evidence-based practice.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">It's too bad it didn't come out years earlier.  Perhaps my mother would not have gone through a year of horrible suffering and death, with me as sad witness, due to the toxic effects of bad health IT.  </span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">Perhaps you should hear how horrible it was to hear my mother in an extended agitated delirium; to hear her cry hysterically later on when the rehab people told her that her weight was 95 pounds; to have to make her a "no code" and put her on hospice-care protocols, and then to have watched her aspirate a sleeping pill when she was agitated, and die several days later of aspiration pneumonia and sepsis ... in the living room of my home ... and then watch the Hearse take her away from my driveway...as a result of bad health IT.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">I will be writing more thoughts on your article at the Healthcare Renewal blog, of course, but wanted to raise three issues:</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">1.  The use of "may" and "will" is reversed, and conflating the term "anecdote" with risk management-relevant case reports.  </span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><i><br /></i></span></span><br /><ul><li><span style="font-size: small;"><span style="font-family: inherit;"><i>They <b>may</b> also represent a potential health IT-related error yet to happen.  --->  </i><i>They<b> likely</b> represent a potential health IT-related error yet to happen</i></span></span></li></ul><ul><li><span style="font-size: small;"><span style="font-family: inherit;"><i><b>Anecdotal </b>reports suggest that these application differences result in an increased training burden for EHR users.  ---> <b>Credible reports indicate</b>...</i></span></span></li></ul><ul><li><span style="font-size: small;"><span style="font-family: inherit;"><i><b>Some suggest</b> that the expected gains sought with the adoption of EHR are not yet realized. ---> <b>Credible experts opine</b> ....</i></span></span></li></ul><div dir="ltr"><ul><li><span style="font-size: small;"><span style="font-family: inherit;"><i><b>Some </b>experts <b>suggest</b> that improving the usability of EHR may be critical to the continued successful diffusion of the technology.</i> --->  "<b>Credible experts opine</b> that ..."</span></span></li></ul></div><div dir="ltr"><ul><li><span style="font-size: small;"><span style="font-family: inherit;"><i>The adoption of useful and usable EHR <b>will</b> lead to safer and higher quality care, and a better return on investment for institutions that adopt them. ---> </i><i>The adoption of useful and usable EHR <b>may</b> lead to safer and higher quality care</i></span></span></li></ul></div><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">You really need to show more clarity ... and guts ... in papers like this, and drop the faux academic weasel words.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">2.  You neglected to speak to the best source for information on EHR-related harms, evidence spoliation, etc...<b> med mal attorneys.</b></span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">3.  You also neglected to speak to, or cite, the writings of a Medical Informaticist on bad health IT now going back 15 years - and whose mother was injured and died as a result of the issues you write about - me.  In fact I am rarely cited or mentioned by anyone with industry interests.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">An apparent contempt for 'whistleblowers' such as myself makes me wonder ... what kind of people are the leaders of health IT, exactly?  </span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><b><br />Do they value computer's rights over patients'?</b></span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">It is not at all clear to me which has been the primary motivator of many of the health IT leaders.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">I think the rights which I value are quite clear.</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">Sincerely,</span></span><br /><span style="font-size: small;"><span style="font-family: inherit;"><br /></span></span><span style="font-size: small;"><span style="font-family: inherit;">Scot Silverstein</span></span></div></blockquote></div></div><br />I neglected to mention the horror of seeing my mother put in a Body Bag before being taken to the Hearse in my driveway.<br /><br />-- SS

AMIA: Enhancing patient safety and quality of care by improving the usability of EHR systems, but ... no sympathy for victims of bad health IT?

A panel of experts from the American Medical Informatics Association have written a paper " Enhancing patient safety and quality of car...

Đọc thêm »

Broken Promises: Latest HCA Settlement Suggests Skepticism about the Next Big Thing in Health Care

A long time ago in the US, most people got care from physicians who were self-employed, or part of physician partnerships.  If they had to be hospitalized, it was at hospitals that were community or academic non-profit organizations.   If they had health insurance, it was likely from a non-profit Blue Cross Blue Shield affiliate.  However, with the rise of market fundamentalism, we have heard the promises of increased efficiency and innovation from for-profit health care.  So hospitals, insurance companies, and now increasingly physicians' practices have been bought up by for profit corporations.<br /><br />Many politicians and policy-makers seemed to believe the promises, and often joined the cheering sections for the latest and greatest for-profit conversions.  Should they have done so?  Let us look at a case that recently hit the news again and think about it..<br /><br /><b>Background - HCA Acquired Health Midwest</b><br /><br />Way back in 2002, large for-profit hospital chain HCA, formerly Columbia/HCA, acquired a sizable non-profit hospital system, Health Midwest.  As the Los Angeles Times then <a href="http://articles.latimes.com/2002/oct/17/business/fi-tenet17">reported</a>,<br /><br /><br /><blockquote class="tr_bq"><div class="area" id="area-article-first-block"><div class="mod-latarticlesarticletext mod-articletext" id="mod-a-body-first-para">In a setback for Tenet Healthcare Corp., rival hospital giant HCA Inc. said Wednesday that it has agreed to buy Health Midwest, a 14-hospital chain based in Kansas City, Mo., for $1.13 billion.<br /><br />Santa Barbara-based Tenet and HCA were the two finalists in a rare opportunity to acquire, in one swoop, a dominant hospital system in a growing urban market. The 20-member board of Health Midwest, a nonprofit company that has been struggling financially, said it voted unanimously to go with HCA.</div></div></blockquote><br />The biggest factor in the decision by the Health Midwest board to accept the HCA offer was apparently the almighty dollar.<br /><br /><blockquote class="tr_bq"> '<i>HCA's bid was much higher</i>,' [Tenet spokesperson Harry] Anderson said, noting that he could not disclose Tenet's offer because of a confidentiality agreement. </blockquote><br />But in addition to cash, HCA made some promises that sounded attractive to the board.<br /><br /><blockquote class="tr_bq"> In addition to the cash price,<i> HCA said it would spend $450 million for capital improvements over the next five years.</i></blockquote><br />That promise came from the top of HCA, as <a href="http://nashvillepost.com/news/2003/4/1/hca_closes_health_midwest_deal_finally">reported</a> by the Nashville post,<br /><br /><blockquote class="tr_bq"> HCA Chief Executive Jack Bovender said: 'This has been a comprehensive, thorough process with a lot of community participation. We are ready to get to work to <i>improve these hospitals through significant capital infusion</i> and by making long term operational improvements.'</blockquote><br /> Furthermore, as the Los Angeles Times also <a href="http://articles.latimes.com/2002/oct/17/business/fi-tenet17">reported</a><br /><br /><blockquote class="tr_bq">Health Midwest spokesman Chris Whitley said <i>price was not the only factor in the decision</i>.<br /><br />'As important to the board was to find a party that would offer <i>a strong commitment to maintain and honor the various religious, cultural and charitable traditions,</i>' he said.</blockquote>There were objections by people who did not have decision making authority, but they apparently did not carry much weight<br /><br /><blockquote class="tr_bq">Labor and community activists in Kansas City have opposed a takeover of a nonprofit health system by an investor-owned corporation, raising concerns that such a conversion would lead to cuts, hurting employees and consumers.</blockquote><br />In retrospect, why Health Midwest was so trusting of HCA at the time was unclear.  HCA, after all, did not have a track record then that should have inspired trust.  The HCA acquisition of Health Midwest was approved only a few years after what was then Columbia/ HCA settled allegations of extensive Medicare fraud.  the $1.7 billion the company paid made it the largest Medicare fraud case settled up to that time (and was larger than the amount it later spent on this acquisition.    See <a href="http://hcrenewal.blogspot.com/2010/05/how-did-ceo-who-presided-over-company.html">this post</a> for some details and sources.)  This certainly could have raised a "red flag" before the deal was concluded.  But it did not. <br /><br />This deal was typical of many deals in which for-profit corporations, some backed by <a href="http://hcrenewal.blogspot.com/search/label/private%20equity">private equity firms</a>, took over sometimes struggling non-profit hospitals, while promising great things for their communities.  For example, see our posts about the take-over of a health care system called <a href="http://hcrenewal.blogspot.com/search/label/Caritas%20Christi">Caritas Christi</a>, by <a href="http://hcrenewal.blogspot.com/search/label/Cerberus">Cerberus Capital Management</a>.  Caritas Christi was given the reassuring name of <a href="http://hcrenewal.blogspot.com/search/label/Steward%20Health%20Care">Steward Health Care</a>, and then proceeded to take over, or try to take over additional hospitals. (Click the links for this long story.)   <br /><br /><b>Broken Promises - the New HCA Settlement </b><br /><br />A new legal settlement by HCA suggests that such takeovers of non-profit hospitals by for-profit corporations ought to be regarded with much greater skepticism.  This time, <a href="http://www.nytimes.com/2013/01/25/business/hca-must-pay-kansas-city-foundation-162-million.html">per the New York Times</a>, <br /><br /><blockquote class="tr_bq"><i>HCA, the nation’s largest profit-making hospital chain, was ordered on Thursday to pay $162 million after a judge in Missouri ruled that it had failed to abide by an agreement to make improvements to dilapidated hospitals</i> that it bought in the Kansas City area several years ago. </blockquote><br />Thus the new HCA settlement suggested that those fine promises made by HCA executives and their cheer leaders when HCA was seeking to take over Health Midwest were broken.<br /><br /><blockquote class="tr_bq"><div itemprop="articleBody">The trouble in the Kansas City area began a year after HCA acquired a dozen hospitals from Health Midwest in 2003 for $1.125 billion. As part of the deal, <i>HCA agreed to make $300 million in capital improvements in the first two years and an additional $150 million in the following three. The hospital chain also agreed to maintain the levels of care that had been provided to low-income individuals and families in the area for 10 years. </i></div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">But when the members of the Health Care Foundation of Greater Kansas City, a nonprofit created from the proceeds of the sale of the hospital, received their first report from HCA in 2004 they discovered the hospital was already way behind. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">Of the $300 million it was supposed to spend in the first two years, its own documents showed it had spent only about $50 million, according to Mark G. Flaherty, one of the founding members of the foundation and its general counsel. </div><div itemprop="articleBody"><br /></div>HCA’s reports to the foundation also indicated that the level of charitable care it provided at the system’s large inner-city hospital had fallen while charitable care provided at the more affluent suburban hospital had risen sharply, Mr. Flaherty said. </blockquote><blockquote class="tr_bq"><div itemprop="articleBody">'That was a big red flag to us,' he said.</div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">After repeatedly asking HCA executives for explanations but receiving none, the foundation sued HCA in 2009. The case went to trial for several weeks in 2011. </div></blockquote><br /> Note that there were alleged violations of two key provisions of the original deal, improvements to existing hospitals and guarantees of charitable care.  So here is at least one case, involving the largest US for-profit hospital corporation, showing violation of the sorts of promises that those promoting for-profit take-overs tout as showing at least the goodwill of the new corporate owners.<br /><br /><b>Should the HCA Track Record Have Led to Questions About Trustworthiness? </b><br /><br />It is unclear how often anyone has bothered to check whether similar promises made in other deals were fulfilled.  It appears that such inquiries might actually involve a lot of bother.  Note that in this case it took almost six years for the community foundation to obtain enough information to conclude that HCA had not met its obligations and file a lawsuit, and another almost four years to get the case resolved.<br /><br />The New York Times hinted that there was at least one other inquiry about a contemporaneous HCA deal.  While "a judge ruled in HCA's favor, deciding that Portsmouth Regional Hospital [in New Hampshire] would remain part of HCA after community leaders tried to regain control," the court proceedings did produce<br /><br /><blockquote class="tr_bq"> testimony in a 2011 trial, [in which] a former hospital official claimed he had <i>difficulties getting HCA to pay for what he and others described as critical equipment and facility upgrades</i>. </blockquote><br />Meanwhile, there have been other recent events that should raise further questions about the trustworthiness of HCA going forward.  Last year extensive reporting suggested that HCA hospitals put short-term revenue ahead of patients' welfare through overuse of lucrative cardiac procedures and and undertreatment of poor patients in emergency departments and debilitated patients with bed sores (see <a href="http://hcrenewal.blogspot.com/2012/08/paging-doctor-ebdita-how-private-equity.html">this post</a>).   Also last year HCA settled allegations it provided kickbacks to physicians at some of its hospitals to refer patients to its hospitals (see <a href="http://hcrenewal.blogspot.com/2012/09/just-latest-legal-settlement-for-hca.html">this post</a>).      <br /><br />Moreover, the record over the long term raises a big question as to why the good people of Missouri, the "show me" state, trusted HCA sufficiently for hospital acquisition deal to go forward in 2003.  As we wrote above, HCA was only a few years out of making the biggest settlement for federal health care fraud known at that time. <br /><br /><b>Summary </b><br /><br /> In 2010, we <a href="http://hcrenewal.blogspot.com/2010/04/more-doubts-about-private-equity-taking.html">suggested</a> that the take-over of non-profit hospitals by for-profit firms owned by private equity ought to be viewed with extreme skepticism.  In 2010, in<a href="http://wendellpotter.com/deadlyspin/"> <i>Deadly Spin</i></a>, former CIGNA public relations chief Wendell Potter showed how the conversions of non-profit Blue Cross Blue Shield health insurance plans to for-profit corporations were justified by the need to gather more capital to provide services comparable to new for-profit competitors, but were really motivated by the greed of executives who "would earn bigger pay packages for managing larger businesses, and if they could convert them to for-profit companies, they stood to earn even more." <br /><br />I submit that if anyone were able to look carefully at the results of the various deals that allowed for-profit corporations to take over hospitals, other organizations that directly take care of patients, health insurance companies, and now even physicians' practices, they would likely find that a lot of fine sounding promises made were broken and assurances made were false.   <br /><br /><br />From now on, I can only hope that health care professionals, policy-makers, politicians, but mainly the public at large will be appropriately skeptical of the fluffy promises made by those who stand to personally gain from the latest big thing in health care.  In particular, we all should be acutely skeptical the next time someone promises lower costs, better care, innovation, etc, etc by converting a community non-profit hospital to a subsidiary of a big for profit corporation.  

Broken Promises: Latest HCA Settlement Suggests Skepticism about the Next Big Thing in Health Care

A long time ago in the US, most people got care from physicians who were self-employed, or part of physician partnerships.  If they had to b...

Đọc thêm »

How the HIT zealots and profiteers have harmed physicians and nurses, not to mention patients, taxpayers, and the government

Any new technology introduced into a complex system, especially when introduced recklessly, has the potential to produce unexpected consequences, and the problems introduced can be worse than the problems the technology was attempting to solve.  This is a fundamental precept and empirical observation in the field of <a href="http://rkcsi.indiana.edu/" target="_blank">social informatics</a>, a domain that studies <span class="st">information and communication tools in their cultural or institutional contexts.</span><br /><br /><span class="st">Idealism combined with <a href="http://www.merriam-webster.com/dictionary/zealotry" target="_blank">zealotry</a> (</span><span class="st"><span class="ssens">excess of zeal;<b> </b>fanatical devotion</span>) and/or hyper-enthusiasm that ignores the downsides of an intervention, and silences credible critique,  has also proven to be a dangerous combination.</span><br /><br />Characteristic of the health IT hyper-enthusiasts been zealotry, silencing of credible critics, and spreading of illusory memes and technologies not yet fit for purpose; the characteristics of HIT profiteers is similar but for a different motive.  The end result in either case is harm to the interests and well-being of patients, physicians and nurses and other clinicians, taxpayers, and the government.<br /><br />(Doctors and nurses ... after reading the findings below, be prepared to countersue the health system officers who mandated your use of EHR's for breach of fiduciary responsibilities, including due diligence, if you are sued for EHR-caused medical malpractice.)<br /><br />---<br /><br /><blockquote class="tr_bq"><b>Medscape </b><br /><b>Business of Medicine</b><br /><a href="http://www.medscape.com/viewarticle/765567" target="_blank">Malpractice 'Discovery' Dangers in Your EHR</a><br />Leslie Kane, MA<br />Jul 16, 2012<br /><br />Introduction<br /><br />Picture this: You've been sued, and now the plaintiff attorney has the right to send in an expert to sit at your computer and examine information in your electronic health record (EHR). Besides any mistakes you might have made, <b>system-wide bugs or design flaws that lead to data inconsistencies could be found and held against you</b> in the discovery phase of a malpractice lawsuit.<br /><br />Doctors are becoming increasingly aware that EHRs can create certain malpractice risks. However, an expert in EHR and liability says there is a new category of malpractice risks in EHRs that most doctors have never considered. These include EHR system issues <b>that you were never aware of and didn't cause.</b></blockquote><br />You may have been coerced into using the EHR system via threat of Medicare cuts -- embedded without a public comment period in the HITECH section of ARRA thanks to the zealots and profiteers -- or via draconian hospital policies set by senior executives that threaten adverse personnel actions or other retaliation for those who refuse to use or are unable to learn to "effectively" use the corporate-chosen EHR (I have seen such policies in print).<br /><br />These executives have simply taken the word of the sellers that the technologies are harmless, and have likely negligently signed hold-harmless agreements with the sellers as a symbol of their confidence in the assessment.<br /><br /><blockquote class="tr_bq">"Every aspect of EHR selection, implementation, and use may be examined in the course of medical malpractice discovery to uncover the source of the incident, or undermine the records that are being presented in defense of the malpractice claim," says Ronald B. Sterling, CPA, MBA, national EHR expert, Silver Spring, Maryland, and author of Keys to EMR Success (Greenbranch Publishing; Phoenix, Maryland; second edition, 2010). "Anything could be a malpractice issue, from the product itself, the way it was set up, or how you've been using it."</blockquote><br />The same applies, I add, to any technology a clinician or healthcare facility might introduce into practice.<br /><br /><blockquote class="tr_bq">For example, authorized software upgrades can unknowingly cause liability problems. Upgrades to the software can change the historical data presentation you've already worked with. "An EHR upgrade can go back and affect data being stored for a patient," says Sterling. "The upgrade can affect the presentation and the reporting and usage of that information. I'm aware of upgrades in which a large amount of data was lost."</blockquote><br />I'm aware of numerous "upgrades" that nearly caused catastrophes - in fact they may have caused catastrophes that were not publicized- such as <a href="http://hcrenewal.blogspot.com/2010/08/huffington-post-investigative-fund-fda.html" target="_blank">here</a>.<br /><blockquote class="tr_bq"><br />"Even if the practice does everything perfectly, there could be <b>design flaws in the electronic health record</b> or the way the practices uses it or sets it up. This gets exposed in the light of discovery during a malpractice suit. <b>If the plaintiff attorney spots errors in the record -- even if the system, not the physician, creates them -- it calls into question every record you produce and every statement you make."</b></blockquote><br />Considering the evidence spoliation that can and does occur thanks to electronic systems, of which I am becoming aware of an increasing number of incidents, discrepancies ("errors" in the record) should arouse suspicions.   Those "hold harmless" agreements should look less and less appealing....<br /><br /><blockquote class="tr_bq">... "There are all kinds of issues I can now delve into, more than I'd find in the paper world. In the paper world, there is not a lot of supporting information," he says. "However, with an EHR, <b>you can see what time each event or note happened, whether it was before or after another event.</b> These could become critical points in a trial."</blockquote><br />Thank the zealots for this, docs.<br /><br />Sterling described several types of problems that could create difficulties for a doctor in a malpractice liability case.<br /><br /><blockquote class="tr_bq">... System or product bugs (defects). One doctor was using an EHR that had inherent errors in it. It wasn't documenting information correctly. The information being entered was not being stored in the right location, and the patient's medical note was ultimately incorrect. "This now calls into question anything in the note, even if you did the right thing," says Sterling.</blockquote><br />Caveat emptor.<br /><br /><blockquote class="tr_bq">Transferring paper records to EHR. What happens to the patient's history that was stored in the paper medical chart? The new EHR form may not specifically account for or match up with every notation you have in the old medical chart. If some information doesn't get transferred in, the plaintiff attorney may ask, "Did the doctor have the full picture of the patient's condition?" The discovery process may include comparing the patient's old paper record (if you still have it) with the history now in the EHR.<br /><br />Signing notes. Some doctors don't sign their notes. This creates a problem with billing, but it also could prompt the question of whether the doctor actually provided those services to the patient.</blockquote><br />The zealots never considered these issues, or didn't care.   "You're going to use EHR's whether you like it or not, because they <b>WILL</b> transform medicine.  So say we all."<br /><br /><blockquote class="tr_bq">... One physician was inadvertently distributing clinical notes that included inappropriate findings (such as results of tests that would not have been given to that patient). When the note was challenged during a malpractice trial, it called the patient's entire record into question.<br /><br />"Unfortunately, the physician had been using software that contained the test setups from the vendor," explained Sterling. "He was recording information on the screen and printing it, and the printed copy was appropriate when he gave it to the patient, but the electronic record contained inappropriate findings and events. Because the doctor was using the forms that contained the original test data (even though the data were not quite visible), the EHR incorporated these old findings."</blockquote><br />Just a "glitch", of course.   <br /><br /><blockquote class="tr_bq">One template affects other screens. When you use templates and you're charting by exception, you're viewing 1 screen. But when you check off items in the box, it sends those data to 5 or 6 other screens, and you may not be aware that the information is now contained on those screens. A doctor may decide to remove the information on 1 screen, but that deleted information has already populated 6 other areas and is still in the patient's medical record.</blockquote><br />Why would one expect that using tools of <a href="http://www.wapatientsafety.org/downloads/article-8.pdf" target="_blank">grossly inappropriate provenance</a> would <b>not </b>create problems?<br /><br /><blockquote class="tr_bq">Usage issues. The vendor stored it one way, but the doctor stored information another way, which changed the location in which information was stored. The historical record actually changed.<br /><br />"What happened when the doctor could not produce the record he gave to the patient because it no longer existed?" asked Sterling. "The attorney would look at it and say, 'This is not the piece of paper you provided.' "Any of these could be the killer issue that ends your chance of successfully defending yourself in a malpractice trial," he says.</blockquote><br />Sure, EHRs will 'revolutionize' medicine, once the EHRs actually don't introduce booby-traps to the practice of medicine exposing clinicians to the revolutionary guillotine.<br /><br /><blockquote class="tr_bq">Vendor Says, "Not My Fault!"<br /><br />One might think that a product defect or design flaw should be the responsibility of the vendor, and the doctor should be held harmless for those types of errors. But it doesn't work that way.<br /><br />"The doctor can be held liable because most vendors' contracts (signed by the physician) essentially say, 'We do not practice medicine; it is up to the physician to make sure this EHR is being used correctly.' The practices have to understand what they're using and verify that the system is appropriately set up to document the care they provide."</blockquote><br />I note that doctors forced to use hospital EHR's never see nor sign those contracts.<br /><br /><blockquote class="tr_bq">In a trial, the doctor would be held responsible for product problems.<br /><br />But just as scary, doctors could be held responsible for following vendor instructions. "I've seen situations in which the vendor tells doctors to do something, and doctors are relying on vendor and not doing their own proper analysis and design of the EHR that's tailored for their own practice," says Sterling. <b>"The vendor is not the one responsible for maintaining the patient's medical record."</b></blockquote><br />More than $20 billion of taxpayer "incentive" money has already gone to the accountability-free sellers of this technology, I might add.  <br /><br /><blockquote class="tr_bq">Bad News: You Need to Delve Into Technicalities<br /><br />Most doctors are unprepared to explore the technical elements of working with an EHR. "Doctors have to understand what happens when you push the buttons," says Sterling. That means they have to take the time to work with the EHR and explore various screens and scenarios before they ever use it with a patient.</blockquote><br />It would help to have people who actually know what they're doing around, a lesson hospitals have not yet fully learned when they depend on grossly inappropriate personnel of a business-computing background to lead HIT projects and make critical decisions on vendor contracts.<br /><br />In summary, the HIT hyper-enthusiasts and profiteers have successfully conned the government and healthcare sector into using, or coercing clinicians to use, technologies unproven to provide the fantastical levels of clinical and financial benefit claimed (as in many other posts), that introduce booby-traps to users' legal safety, that can be injurious to patient safety, and that suck money from healthcare that could be better used in, say, care of the underserved.<br /><br />What an enviable arrangement for the enthusiasts.<br /><br />-- SS

How the HIT zealots and profiteers have harmed physicians and nurses, not to mention patients, taxpayers, and the government

Any new technology introduced into a complex system, especially when introduced recklessly, has the potential to produce unexpected conseque...

Đọc thêm »

Senator Stephen H. Martin of Virginia: proposed limitations on use, storage, sharing, & processing of electronic medical record data

Here's a politician who certainly seems concerned with the <a href="http://hcrenewal.blogspot.com/search/label/medical%20record%20privacy" target="_blank">privacy and confidentiality</a> and <a href="http://hcrenewal.blogspot.com/2009/04/have-we-suffered-complete-breakdown-in.html" target="_blank">flawed-analysis</a> downsides of electronic health records -  <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?131+mbr+S41" target="_blank">Senator Stephen H. Martin</a> <span style="font-size: small;">of Virginia<span style="font-size: small;">:</span></span><br /><br /><hr size="1" /><div class="topLine"></div><div class="topLine"><b><a href="http://lis.virginia.gov/cgi-bin/legp604.exe?131+sum+SB1275" target="_blank">SB 1275</a> Medical data in an electronic or digital format; limitations on use, storage, sharing, & processing. </b></div><h4>SUMMARY AS INTRODUCED:</h4><blockquote class="tr_bq"><b>Medical data</b>. Prohibits any person that regularly stores medical data in an electronic or digital format from (i) participating in the establishment or implementation of the Nationwide Health Information Network; (ii) performing any analytic or statistical processing with regard to any medical records from multiple patients for purposes of medical diagnosis or treatment, including population health management; or (iii) processing medical data at a facility within the Commonwealth in any instance where a majority of the patients whose medical data is being processed do not reside in the Commonwealth. A database at which medical data is regularly stored in an electronic or digital format shall not store or maintain in a manner that is accessible by the operator or any other person, in an electronic or digital format, at any one time, medical data regarding more than 10,000 patients. </blockquote><br />Of note, the bill also counters the coercive aspects of the HITECH bill, stealthily sneaked into the Economic Recovery Act (ARRA) without so much as a peep of public comment, thanks to the Health IT lobby (as described by Robert O'Harrow Jr. in the WaPo in May 2009, see <a href="http://hcrenewal.blogspot.com/2009/05/machinery-behind-healthcare-reform-how.html" target="_blank">here</a>):<br /><br /><blockquote class="tr_bq"><b>The measure provides that any health care provider shall not be subject to any penalty, sanction, or other adverse action resulting from its failure or refusal to implement an online computerized medical record system. </b>A patient's consent to the sharing of his health care information shall be presumed not to grant consent to the electronic or digital storing or transmission of the information to any person other than for health care coverage purposes. Finally, the measure prohibits the Commonwealth from authorizing the establishment or operation of a health information exchange. </blockquote><br />The proposal seems authoritarian in terms of use of aggregated, de-identified medical data for public health purposes.  In the current environment, however, of health IT hyper-exuberance, misuse of medical data (e.g., putting it up for sale as at <a href="http://hcrenewal.blogspot.com/2009/10/private-medical-records-offered-for.html" target="_blank">link</a>, <a href="http://hcrenewal.blogspot.com/2009/10/health-it-vendors-trafficking-in.html" target="_blank">link</a>) and repeated major security breaches, perhaps a return to sanity requires putting the brakes on - hard - and performing a 'system reset.'<br /><br />It's clear the hyperenthusiasts will not like this proposed legislation. <br /><br />-- SS

Senator Stephen H. Martin of Virginia: proposed limitations on use, storage, sharing, & processing of electronic medical record data

Here's a politician who certainly seems concerned with the privacy and confidentiality and flawed-analysis downsides of electronic hea...

Đọc thêm »

How the "Revolving Door" and Other Aspects of Corporatism Benefited Amgen Just After its Settlement and Guilty Plea

At least here in these United States, our health care corporatism is bipartisan.  Here we present a sorry story of how a company that should have been shamed by dishonest behavior that likely harmed patients instead apparently was awarded special treatment through its cozy relationships with top government leaders <br />  <br /><b>Accusations of Kickbacks and Deceptive Marketing of Aranesp  </b><br /><br />Last month, biotechnology giant pleaded guilty to a charge of misbranding and settled civil charges with the US government for $762 million (look <a href="http://hcrenewal.blogspot.com/2012/12/amgen-settles-pleads-guilty-to.html">here</a>).  Soon after, New York Times <a href="http://www.nytimes.com/2012/12/20/business/amgen-workers-helped-us-in-aranesp-marketing-inquiry.html">article</a> described the unethical practices the company was alleged to have performed.  It opened with a vivid anecdote:<br /><br /><blockquote class="tr_bq">'I hope no one is taping this,' the Amgen<a class="meta-org" href="http://topics.nytimes.com/top/news/business/companies/amgen_inc/index.html?inline=nyt-org" title="More information about Amgen Inc"></a> manager remarked at a company sales meeting in 2005.<br /><br />The manager then <i>boasted of how she had given a $10,000 unrestricted grant</i> to a pet project of a doctor who was an adviser to the local  Medicare contractor. <i>In turn, she said, the doctor would help persuade the contractor to provide reimbursement for an unapproved use of Amgen’s anemia drug, Aranesp.</i>  </blockquote><br />Since that account appeared to be of a quid pro quo, it did sound like some a kickback or bribery.  In addition, <br /><br /><blockquote class="tr_bq">Amgen is also <i>accused of offering kickbacks to doctors and clinics to induce them to use its drugs</i>. These reportedly came as cash, rebates, free samples, educational and research grants, dinners and travel, and other inducements.   </blockquote><br />Of course, since this was the usual sort of settlement we see of health care corporate wrongdoing, in which the reason the company is paying what appears to be a large fine remains ambiguous,<br /><br /><br /><blockquote class="tr_bq"><div itemprop="articleBody">Except for those in the criminal count, <i>Amgen denied the other accusations, though it did issue a statement on Wednesday acknowledging the settlement</i>. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">'The government raised important concerns in the criminal prosecution,' Cynthia M. Patton, chief compliance officer at Amgen, said in the statement. 'Amgen acknowledges that <i>mistakes were made</i>, and we did not live up to our standards.'</div></blockquote><div itemprop="articleBody"><br />"Mistakes were made," what a handy phrase to avoid acknowledging that a real person or person made those mistakes.  Why government prosecutors did not leverage instances in which the mistakes were made by an identifiable person, for example, the manager in the anecdote above, to find out who ultimately authorized and directed the kickbacks and deceptive marketing, and then seek to indict them is a mystery.  The US Department of Justice now seems to be disinclined to ever pursue top  health care corporate executives who may have done wrong, while they exuberantly pursue fines from the companies they direct, fines which have almost no personal impact on those who authorized, directed or implemented the bad behavior.<br />   <br />The Times article also included a telling allegation that behind this apparent misbehavior was a changed corporate culture that put short-term revenue ahead of all other considerations.  </div><div itemprop="articleBody"><br /></div><blockquote class="tr_bq"><div itemprop="articleBody">the corporate culture changed starting around 2000. That was when new management came in and Aranesp was approved, setting up a fierce marketing battle with Johnson & Johnson and its rival anemia drug, Procrit. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody"><b><i>'It was more important to make your numbers than to follow the rules,' </i></b>said [former Amgen sales representative and now whistle-blower Jill] ...Osiecki, who was based in Milwaukee and sold Aranesp. </div></blockquote><div itemprop="articleBody"><br /></div><div itemprop="articleBody">We have discussed how the "make your numbers" culture seems to have resulted from an over-generalization of the prevalent belief in business schools that "maximizing shareholder value," which usually seems to mean maximizing short-term revenue and/or doing whatever it takes to boost stock prices in the short-term (look <a href="http://hcrenewal.blogspot.com/2012/04/health-care-dysfunction-explained-by.html">here</a>).  In companies which make potentially beneficial but also potentially hazardous drugs, the risks of "make your numbers" are obvious.</div><div itemprop="articleBody"><br /></div><div itemprop="articleBody"><b>Shameful Consequences for Patients  </b></div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">These were disconcerting revelations.  They showed that some unidentified employees, probably including top leaders of a major health care corporation seemed to use kickbacks and lies to deceptively market a drug just to "make their numbers," and thus most likely score healthy bonuses.  Yet this drug is clearly dangerous.  The <a href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103951Orig1s5173_103951Orig1s5258lbl.pdf">official Aranesp label</a> states (in a black box warning, in capital letters):<br /><br /><blockquote class="tr_bq"> ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE</blockquote><br />Thus deceptive and unethical marketing practices likely lead to overuse of the drug, and overuse of the drug likely lead to sick (via myocardial infarction [heart attack], stroke, venous thromboembolism or thrombosis of vascular access [drug clots], or tumor progression) or dead patients. <br /><br />One would think that the consequences of the particular bad behavior alleged in this case would have lead to more zealous prosecution and to the pursuit of actual people who authorized, directed or implemented the bad behavior.  However, it did not.<br /><br /><br />One would also think that the nature and consequences of this bad behavior would harm the reputation of the company and its leadership.  Instead, it appears that soon after the settlement was announced, top US elected leaders were fawning over this company and its leadership, and rushing to legislate special treatment for it.<br /><br /><b>Special Treatment from Legislators </b><br /><br />Yet soon after these disconcerting revelations that should have shamed Amgen and its leadership, it appears that the company benefited from legislation narrowly crafted mainly just for to suit its interests, and with the aid of allies from both parties within the US government.  That story was again just <a href="http://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html">reported </a>by the New York Times.  The basics are:</div><div itemprop="articleBody"><br /></div><blockquote class="tr_bq"><div itemprop="articleBody">Just two weeks after pleading guilty in a major federal fraud case, <i>Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the "fiscal cliff"  bill that did not mention the company by name but strongly favored one of its drugs. </i></div><div itemprop="articleBody">  </div><div itemprop="articleBody">The language buried in Section 632 of the law<a href="http://www.gpo.gov/fdsys/pkg/BILLS-112hr8eas/pdf/BILLS-112hr8eas.pdf" title="American Taxpayer Relief Act"> </a><i>delays a set of Medicare price restraints on a class of drugs that includes Sensipar, a lucrative Amgen pill used by kidney dialysis patients.</i> </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">The provision gives Amgen <i>an additional two years to sell Sensipar without government controls.</i> The news was so welcome that the company’s chief executive quickly relayed it to investment analysts.  But<i> it is projected to cost Medicare up to $500 million over that period.[That would almost make up for the fine the company had to pay for illegal marketing and to settle kickback charges - Ed]</i></div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">Amgen, which has a small army of 74 lobbyists<a href="http://www.opensecrets.org/lobby/clientlbs.php?id=D000000391&year=2012" title="Amgen’s lobbyists as of 2012"> </a>in the capital, was the only company to argue aggressively for the delay, according to several Congressional aides of both parties. </div></blockquote><div itemprop="articleBody"><br /></div><div itemprop="articleBody">But the Times article noted that it was not just the size of its army of lobbyists that did it.  </div><div itemprop="articleBody"><br /></div><blockquote class="tr_bq"><div itemprop="articleBody"> <i>Amgen has deep financial and political ties to lawmakers like Senate Minority Leader Mitch McConnell, Republican of Kentucky, and Senators Max Baucus, Democrat of Montana, and Orrin G Hatch, Republican of Utah, who hold heavy sway over Medicare payment policy as the leaders of the Finance Committee. </i></div></blockquote><div itemprop="articleBody"><br /></div><div itemprop="articleBody">In particular, Amgen</div><div itemprop="articleBody"><br /></div><blockquote class="tr_bq"><div itemprop="articleBody">has a deep bench of <i>Washington lobbyists that includes Jeff Forbes, the former chief of staff to Mr. Baucus; Hunter Bates, the former chief of staff for Mr. McConnell; and Tony Podesta, whose fast-growing lobbying firm has unusually close ties to the White House</i>. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody"><i>Amgen’s employees and political action committee have distributed nearly $5 million in contributions to political candidates and committees</i> since 2007, including $67,750<a href="http://www.opensecrets.org/politicians/contrib.php?cycle=2012&cid=N00004643&type=C"> </a>to Mr. Baucus, the Finance Committee chairman, and $59,000 to Mr. Hatch, the committee’s ranking Republican. They gave an additional $73,000 to Mr. McConnell, some of it at a fund-raising event for him that it helped sponsor in December while the debate over the fiscal legislation was under way. More than $141,000 has also gone from Amgen employees to President Obama’s campaigns. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">What distinguishes the company’s efforts in Washington is the diversity and intensity of its public policy campaigns. <i>Amgen and its foundation have directed hundreds of thousands of dollars in charitable contributions to influential groups like the Congressional Black Caucus and to lesser-known groups like the Utah Families Foundation, which was founded by Mr. Hatch</i> and brings the senator positive coverage in his state’s news media. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody"><i>Amgen has sent large donations to Glacier PAC, sponsored by Mr. Baucus in Montana, and OrrinPAc, a political action committee controlled by Mr. Hatch in Utah. </i></div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">And when Mr. Hatch faced a rare primary challenge last year, a nonprofit group calling itself Freedom Path<a href="http://images.nictusa.com/cgi-bin/fecimg/?C00492504" title="Freedom Path FEC filings"></a> sponsored advertisements in Utah that attacked his opponent, an effort that tax records released in November show was financed in large part by the Pharmaceutical Research and Manufacturers of America<a href="http://www.phrma.org/" title="PhRMA’s Web site"></a>, a trade group that includes Amgen. </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">In some cases, <i>the company’s former employees have found important posts inside the Capitol. They include Dan Todd, one of Mr. Hatch’s top Finance Committee staff members on health and Medicare policy, who worked as a health policy analyst for Amgen’s government affairs office from 2005 to 2009</i>. <i>Mr. Todd, who joined Mr. Hatch’s staff in 2011, was directly involved in negotiating the dialysis components of the fiscal bill, and he met with 'all the stakeholders,</i>' Mr. Hatch’s spokeswoman said, not disputing when asked that this included Amgen lobbyists.</div></blockquote><div itemprop="articleBody"><br />In addition, a NY Times <a href="http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html">editorial</a> today pointed out that Mitch McConnell, the Senate Minority Leader, (Republican - Kentucky) who "exerted great influence over the fiscal negotiations and praised the Medicare provisions" presumably including the specific provision that helped Amgen, also has "political and financial ties to Amgen."  Furthermore, Senator McConnell's willingness to use taxpayer's money to pay Amgen more seemed to contradict his "public statements [which] usually emphasize the need to cut federal spending on entitlement programs, <a href="http://www.lanereport.com/17882/2013/01/entitlement-spending-fix-will-require-medicare-eligibility-age-hike-means-testing-and-cpi-formula-change-mcconnell-says/?utm_source=Faster%20Lane%20Newsletter&utm_medium=Email&utm_campaign=jan-21-2013" target="_blank">as they did in Lexington Friday</a>," as <a href="http://www.weku.fm/post/mcconnell-helped-amgen-delay-price-limits-dialysis-drug">reported</a> by WEKU (the National Public Radio Station at Eastern Kentucky University ).   <br /><br /><br /></div><div itemprop="articleBody"><b>Can We Reform Health Care in the Corporatist States of America?  </b><br /><br /> In summary, Amgen seems to have leveraged its use of former legislative aides affiliated with both political parties as lobbyists, and its presumed influence over former employees who are currently legislative aides, that is, to people who have transited <a href="http://hcrenewal.blogspot.com/search/label/revolving%20doors">revolving doors</a> in both directions, to influence policy in its corporate favor.  It has also leveraged its contributions directly to politicians, to political action committees (PACs), and to non-profit advocacy groups to influence policy in its direction for this purpose.  All this leverage apparently resulted in continuing government favoritism to a company the government had just convicted of a crime, and to a company whose actions likely led to sick and dead patients.  Furthermore, legislators who publicly deplore excess government spending and enlarging government deficits supported spending more taxpayer money to favor a particular company that they ought to have shunned.  <br /><br /><br />The New York Times <a href="http://www.nytimes.com/2013/01/23/opinion/amgen-gets-a-gift-from-congress.html">editorial</a> deplored this case first as<br /><br /><blockquote class="tr_bq">a disheartening example of how intense lobbying and financial contributions can distort the legislative process in Washington</blockquote></div><div itemprop="articleBody"><br />and second as<br /><br /><blockquote class="tr_bq">a classic example of the power of special interests to shape legislation and shows how hard it may be to carry out the reforms needed to cut health care costs. </blockquote><br />But it was really much worse than that.   This case certainly shows the ongoing coziness between big health care organizations and government (this time, mainly legislative) leaders, facilitated by the apparently very common "<a href="http://hcrenewal.blogspot.com/search/label/revolving%20doors">revolving door</a>" interchange of influential people between corporate management and government.  Note that this coziness has now become bipartisan.  However, this was not merely expensive favoritism.  It was hypocritical expensive favoritism that benefited a corporation that ought to have been shamed and shunned for behavior that did not merely cost the government money, but likely harmed patients, sometimes even fatally.  </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody"></div><div itemprop="articleBody">President Theodore Roosevelt <a href="http://www.theodoreroosevelt.org/TR%20Web%20Book/TR_CD_to_HTML364.html">condemned</a> malefactors of great wealth.  Our current political leaders in both parties seem to put their ties to corporate insiders who work for executives of great wealth ahead of any consideration of what might be good for patients, public health, or the citizenry at large.  </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">So the US now seems to be run by a soft, informal version of <a href="http://hcrenewal.blogspot.com/search/label/corporatism">corporatism</a>, the system in which government and big corporations overlap and jointly rule the people.  Since these days big corporations are run largely without accountability by increasingly rich executives, this ends up meaning government by the oligarchs, for the oligarchs, and of the oligarchs.  President Lincoln and President Theodore Roosevelt might be rolling in their graves.  </div><div itemprop="articleBody"><br /></div><div itemprop="articleBody">To meaningfully reform health care, it seems like we need to meaningfully reform our entire political system, and both make leaders of health care organizations accountable, and make government again of the people, by the people, and for the people.  </div>

How the "Revolving Door" and Other Aspects of Corporatism Benefited Amgen Just After its Settlement and Guilty Plea

At least here in these United States, our health care corporatism is bipartisan.  Here we present a sorry story of how a company that should...

Đọc thêm »

The HIT Scam

Worth a read -<br /><h1 class="post-title"><span style="font-size: small;"><a href="http://healthblog.ncpa.org/the-hit-scam/" rel="bookmark" title="Permanent Link to The HIT Scam">The HIT Scam</a><span style="font-weight: normal;"><span style="font-size: small;"> </span>By Greg Scandlen</span></span></h1><h1 class="post-title"><span style="font-size: small;"><span style="font-weight: normal;">Notable in the pi<span style="font-size: small;">ece are these observations:</span> </span></span></h1><blockquote class="tr_bq"><h1 class="post-title"><span style="font-size: small;"><span style="font-weight: normal;"> <span style="font-size: small;">... </span>even the editors of the <a href="http://www.washingtonpost.com/opinions/the-rush-to-digitize-patient-records-has-not-cut-costs/2013/01/14/09d90096-5c2d-11e2-beee-6e38f5215402_story.html?hpid=z3"><i>Washington Post</i></a> have come to agree the whole [national health I<span style="font-size: small;">T] </span>project was a fiasco — but only after we wasted $27 billion of taxpayer money. </span></span></h1>Yet, those who are enriching themselves on the $27 billion are just happy as clams over the program. John Hoyt, the Executive Vice President of the Healthcare Information and Management Systems Society (HIMSS) was quoted in a recent Health Change Bulletin as saying −<br /><br /><div style="padding-left: 30px;">This data suggests that the HITECH portion of the 2009 stimulus law is achieving its intended result of encouraging increased implementation and meaningful use of electronic health records among hospitals. Facilities…are laying the groundwork for interoperability to occur. Stage 6 and Stage 7 hospitals are fully prepared for provider-to-provider or facility-to-facility interoperability, as well as increasing the provider or facility’s ability to provide electronic health data reporting to public health and immunization registries to support population health review and syndromic surveillance.</div><div style="padding-left: 30px;"><br /></div>There, aren’t you greatly reassured? By the way, the <i>New York Times</i> piece cited above reported that –<br /><br /><div style="padding-left: 30px;">RAND’s <a href="http://www.rand.org/pubs/monographs/MG408.html" title="Abstract of the report.">2005 report</a> was paid for by a group of companies, including General Electric and Cerner Corporation, that have profited by developing and selling electronic records systems to hospitals and physician practices. Cerner’s revenue has nearly tripled since the report was released, to a projected $3 billion in 2013, from $1 billion in 2005.</div><div style="padding-left: 30px;"><br /></div>No doubt the companies that paid for the RAND study are also members of HIMSS. And General Electric certainly has what might be called a “special” relationship with President Obama.</blockquote><h1 class="post-title"><span style="font-size: small;"><span style="font-weight: normal;">I've <span style="font-size: small;">been writing on <span style="font-size: small;">similar issues for more than a decade.</span></span></span></span></h1><h1 class="post-title"><span style="font-size: small;"><span style="font-weight: normal;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">It's well past the time when <span style="font-size: small;">the same rigor that applies to pharma and medical devices be <span style="font-size: small;">applied to the health IT sector<span style="font-size: small;">.  And the marketing hype, along with bad health IT, abolished.</span></span></span></span></span></span></span></span></h1><h1 class="post-title"><span style="font-size: small;"><span style="font-weight: normal;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;"><span style="font-size: small;">-- SS</span> </span></span></span></span></span></span></span></span> </h1><span style="font-size: small;"> <a href="http://healthblog.ncpa.org/author/gscandlen/" rel="author" title="Posts by Greg Scandlen"></a></span>

The HIT Scam

Worth a read - The HIT Scam By Greg Scandlen Notable in the pi ece are these observations:   ... even the editors of the Washington Post ...

Đọc thêm »

GUEST BLOG - What Can Doctors Do to Combat Business Malfeasance in Health Care?

<span style="color: blue;"><i>Dr Gene Dorio is a an internist and geriatrician in California, <a href="http://articles.latimes.com/2011/nov/27/local/la-me-1127-lopez-dorio-20111127">described</a> in the Los Angeles Times as an "old school physician."  He would welcome discussion with anyone interested in his proposal.  Please email him directly at <span class="gI"><span class="go">grd51 at aol dot com, or email me for forwarding.  </span></span>   </i></span><br /><br />As a <a href="http://hcrenewal.blogspot.com/">Health Care Renewal</a> reader, learning of medical business malfeasance irritates my moral conscience, yet lack of legal intervention frustrates my inner core.<br /><br />I am chairman of the Department of Medicine at a small community hospital in Southern California, and as I battle the Administration during Medical Executive Committee meetings, I am a lone voice. Some of my colleagues nod their heads, while others later tell me of their support, but few vocally nor in writing openly give their opinion. Why? <br /><br />Most fear hospital financial retaliation, but I also know they don’t have time to formulate an opinion. You would think well-educated doctors who daily advocate on behalf of patients would be better attuned to being involved in our great medical debate. Because they have remained silent, “big business” jumped in and took over financial medical decision-making. <br /><br />Using our medical license is the business scheme they use to make their money. With sophisticated business techniques, they have shut out doctors and dangled dollars as we all jump for their “carrots.” That successful business model and attitude is outside the realm of doctor’s poor business and public relations sense, with the noose continually tightening. <br /><br />Realizing business would be nowhere without our medical license is our trump card...which we haven’t played yet! <br /><br />What can we do? Logically, bring their business malfeasance forward on blogs (like <a href="http://hcrenewal.blogspot.com/">Health Care Renewal</a>) with the hope physicians and the public will be upset. It does stir the pot for some of our colleagues, but for the most part, doctor attention is now focused on just trying to survive. The public is rendered helpless by the continually confusing medical legalese by the well-financed business propaganda machine. This is where our frustration arises, as the backlash-opinion tsunami of their business outrage never materializes, especially from doctors. <br /><br />Therefore, my first thought for a possible solution is focus on the public, clarifying the legalese, and use abhorrent stories of business abuse and patient care sacrifice for business profit. We must make them the villain. <br /><br />Secondly, organize physician writers into a small group launching a “counter offensive” against their propaganda. The public still highly respect physicians and gravitates to their opinions and stories. With the right motivated people, they would think-tank refined opinions for the national spotlight. <br /><br />Thirdly, network with national blogs and magazines, and city-printed newspapers for article publication as op-eds, letters to the editors, journal articles, and personal stories. <br /><br />Fourthly, and probably the hardest, not get discouraged. <br /><br /><a href="http://hcrenewal.blogspot.com/">Health Care Renewal</a> defines the problem, but not always the solution. Even when there might be solutions, they must be broadcast and directed at a higher level to ignite public opinion. <br /><br />If you think this might be worthy for 2013 (as if we aren’t all busy enough!), I will be happy to spearhead this project with those advocate colleagues and idealists who might be interested. <br /><br />Our profession is under assault from big business, and finding clarity is the shield we need to defend society and our patients.<br /><br />Dr Gene Dorio

GUEST BLOG - What Can Doctors Do to Combat Business Malfeasance in Health Care?

Dr Gene Dorio is a an internist and geriatrician in California, described in the Los Angeles Times as an "old school physician." ...

Đọc thêm »